Impact of Thyroid Hormones on Serum Prostate Specific Antigen Level in Patients with Benign Thyroid Disorders
Journal Title: Journal of Urological Surgery - Year 2020, Vol 58, Issue 4
Abstract
Objective: The aim of the present study was to evaluate whether thyroid hormone levels in benign thyroid disorders resulting in hypothyroidism or hyperthyroidism had an impact on the levels of serum prostate specific antigen (PSA). Materials and Methods: A total of 50 male patients aged between 40 and 75 years who had newly diagnosed benign thyroid disorders were enrolled in this study. Patients with hypothyroidism (n=19) were enrolled as group 1 and patients with hyperthyroidism (n=31) as group 2. Before the initiation of medical treatment, levels of serum total, free PSA, and thyroid hormones were measured. Patients then received appropriate medical treatment for their thyroid disease. Once patients were noted to have achieved normal thyroid function tests in the second month following treatment initiation, serum total and free PSA levels were once again measured. Results: The mean age of the patients was 56.7 years. The mean pretreatment serum total PSA levels in group 1 and 2 were 1.5 and 2.6 ng/mL, respectively (p=0.03). Although group 1 patients had lower posttreatment mean serum total PSA levels (1.7 ng/mL) compared to group 2 (2.5 ng/mL), the difference was not statistically significant (p=0.15). In the comparisons of pre and posttreatment serum total PSA, free PSA and free/total PSA (%) levels in both groups, no statistically significant difference was found (p>0.05). Conclusion: Our results showed that decreased serum thyroid stimulating hormone and increased serum T3 and T4 levels were associated with increased serum PSA levels. It was also observed that there was no alteration in serum PSA level in relationship to medical treatment received.
Authors and Affiliations
Çağdaş Şenel, Altuğ Tuncel, Yılmaz Aslan, Dilek Berker, Merve Çatak, Serdar Güler, Melih Balcı
Keywords
Related Articles
- EP ID EP691530
- DOI 10.4274/jus.galenos.2020.3388
- Views 147
- Downloads 0
Primary Urothelial Carcinoma of the Anterior Urethra
We report the case of an 89-year-old male with an isolated anterior urethral invasive urothelial carcinoma. This is a rare primary tumour of the anterior urethra, as this area is not lined by urothelium. It was managed w...
An Overview of the Advantages of Digital Flexible Ureteroscopes. A Review by Young Academic Urologists Endourology and Urolithiasis Working Party of the European Association of Urology
Endoscopic technology is the cream of the crop for the urinary tract endoscopic procedures in our modern era of surgery. The idea of this review was to evaluate different characteristics of fiberoptic (FO), reusable digi...
Which One Is More Effective for Lower Urinary Tract Dysfunctions in Children? Pelvic Floor Contraction or Pelvic Floor Relaxation in Biofeedback Therapy
Objective: The objective of this study is to investigate the results of contraction- and relaxation-based biofeedback (BF) in children with lower urinary tract dysfunction (LUTD). Materials and Methods: Between 2007 and...
Evaluation of Sleep Quality and Quantity of Patients with Benign Prostatic Hyperplasia Using the Medical Outcomes Study-sleep Scale
Objective: This study aimed to evaluate the sleep quality and quantity of patients with benign prostate hyperplasia (BPH) and compare them with that of a control group using the Medical Outcomes Study-sleep scale (MOS-SS...
Insights into the Management of Overactive Bladder: What Difference Can Mirabegron Make?
Oral pharmacotherapy constitutes second-line treatment for overactive bladder (OAB) after lifestyle modifications, bladder retraining, and pelvic floor muscle exercises. Antimuscarinics have an established role in the tr...